Comparison 11. Levetiracetam versus lorazepam IV.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Non‐cessation of seizure	1	79	Risk Ratio (M‐H, Fixed, 95% CI)	0.97 [0.44, 2.13]
2 Siezure recurrence at 1‐24 h	1	60	Risk Ratio (M‐H, Fixed, 95% CI)	0.64 [0.27, 1.54]
3 Hypotension	1	44	Risk Ratio (M‐H, Fixed, 95% CI)	0.23 [0.05, 0.96]
4 Respiratory failure	1	44	Risk Ratio (M‐H, Fixed, 95% CI)	0.46 [0.19, 1.12]
5 Death	1	44	Risk Ratio (M‐H, Fixed, 95% CI)	1.01 [0.51, 2.00]
6 Ventilatory need	1	44	Risk Ratio (M‐H, Fixed, 95% CI)	0.37 [0.13, 0.99]